Twin Tree Management, LP Abb Vie Inc. Put Options Transaction History

Twin Tree Management, LP

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $19.4 Million - $23.6 Million	118,200 Added 144.5%	200,000 $39.5 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $2.45 Million - $2.86 Million	15,800 Added 23.94%	81,800 $14 Million
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $10.5 Million - $12 Million	66,000 New	66,000 $12 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $1.32 Million - $1.45 Million	-12,900 Reduced 20.87%	48,900 $5.29 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $5.63 Million - $7.04 Million	-78,000 Reduced 55.79%	61,800 $5.47 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $5.95 Million - $7.61 Million	-90,600 Reduced 39.32%	139,800 $10.2 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $2 Million - $2.35 Million	25,900 Added 12.67%	230,400 $18.6 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $6.38 Million - $7.86 Million	-81,900 Reduced 28.6%	204,500 $18.9 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $19.5 Million - $21.7 Million	-219,300 Reduced 43.37%	286,400 $27.1 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $24.7 Million - $29.2 Million	274,800 Added 119.01%	505,700 $46.9 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $16.1 Million - $21.6 Million	175,400 Added 316.04%	230,900 $21.9 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $10.7 Million - $11.8 Million	-119,800 Reduced 68.34%	55,500 $5.37 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $12.2 Million - $15.6 Million	175,300	175,300 $15.6 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $323B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.